XML 54 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Common Stock Warrants
12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Common Stock Warrants
Stockholders’ Equity
Redeemable Convertible Preferred Stock
We recorded our redeemable convertible preferred stock at fair value on the dates of issuance, net of issuance costs. Prior to the automatic conversion to our common stock in conjunction with our IPO, we classified our redeemable convertible preferred stock outside of stockholders’ deficit because it was redeemable in the future at the option of our preferred stock holders. We had concluded that the convertible preferred stock was considered probable of becoming redeemable. Accordingly, redeemable convertible preferred stock was accreted for the difference between the initial net carrying value and the redemption value on April 10, 2023, the earliest redemption date using the effective interest rate method. During the years ended December 31, 2019, 2018 and 2017, we recognized accretion of $0.1 million, $0.2 million, and $0.1 million, respectively, as an increase in the carrying value of the redeemable convertible preferred stock, and a decrease to our additional paid-in capital.
In March 2017, we issued 11,773,932 shares of Series D redeemable convertible preferred stock for total consideration of $52.5 million. The original issue price and initial conversion price of Series D redeemable convertible preferred stock was $4.4590 per share. Series D redeemable convertible preferred stock had the same liquidation preference, voting rights and conversion rights as Series B and Series C redeemable convertible preferred stock. The holders of Series D redeemable convertible preferred stock were entitled to receive noncumulative dividends, prior to and in preference of any declaration or payment of any dividends on the common stock, at a rate per annum of $0.3568 per share. Upon issuance of Series D redeemable convertible preferred stock, we increased the authorized number of shares to 80,000,000 shares of common stock and 45,960,013 shares of redeemable convertible preferred stock. We also revised the redemption rights of redeemable convertible preferred stock such that all series of outstanding redeemable convertible preferred stock are eligible to be redeemed for cash in full upon a written notice by a majority of the holders on or after March 10, 2022.
In April 2018, we issued 12,655,477 shares of Series E redeemable convertible preferred stock for a total consideration of $105.0 million. The original issue price and initial conversion price of Series E redeemable convertible preferred stock was $8.2968 per share. Series E redeemable convertible preferred stock had the same liquidation preference, voting rights and conversion rights as Series A, Series B, Series C and Series D redeemable convertible preferred stock. The holders of Series E redeemable convertible preferred stock were entitled to receive noncumulative dividends, prior to and in preference of any declaration or payment of any dividends on the common stock, at a rate per annum of $0.6638 per share. Upon issuance of Series E redeemable convertible
preferred stock, we increased the authorized share number to 99,250,000 shares of common stock and 58,615,488 shares of redeemable convertible preferred stock. We also revised the redemption rights of redeemable convertible preferred stock such that all series of outstanding redeemable convertible preferred stock were eligible to be redeemed for cash in full upon a written notice by a majority of the holders on or after April 10, 2023.
In conjunction with our IPO in July 2019, all shares of redeemable convertible preferred stock then outstanding, totaling 58,615,488 shares, were automatically converted into an equivalent number of shares of common stock on a one-to-one basis and their carrying value, totaling $237.0 million, inclusive of accretion of redeemable convertible preferred stock, was reclassified into stockholders’ equity on our consolidated balance sheets. No shares of redeemable convertible preferred stock were issued or outstanding as of December 31, 2019.
Redeemable convertible preferred stock outstanding as of December 31, 2018 consisted of the following:
 
December 31, 2018
 
Shares
Authorized
 
Shares
Issued and
Outstanding
 
Net
Carrying
Value
 
Aggregate
Liquidation
Preference
 
(in thousands)
Series A
10,394

 
10,394

 
$
10,382

 
$
10,650

Series B
8,935

 
8,935

 
19,957

 
20,000

Series C
14,857

 
14,857

 
49,407

 
49,500

Series D
11,774

 
11,774

 
52,397

 
52,500

Series E
12,655

 
12,655

 
104,786

 
105,000

Total redeemable convertible preferred stock
58,615

 
58,615

 
$
236,929

 
$
237,650


Prior to the conversion of the redeemable convertible preferred stock to common stock in July 2019, the stockholders of redeemable convertible preferred stock had the following rights, preferences, and privileges:
Dividend Rights
The holders of Series A, Series B, Series C, Series D and Series E redeemable convertible preferred stock were entitled to receive non-cumulative dividends, out of any assets legally available, prior and in preference to any declaration or payment of any dividend on the common stock at the rate of $0.081968, $0.1824, $0.2666, $0.3568, and $0.6638 per share, respectively (as adjusted for stock dividends, stock splits, combinations, or other similar recapitalizations) per annum on each outstanding share, when, as, and if declared by the board of directors. As of December 31, 2019 and 2018, we have never declared nor paid dividends.
Liquidation Preference
In the event of our voluntary or involuntary liquidation, dissolution, or winding up, or a deemed liquidation event, the holders of each series of redeemable convertible preferred stock outstanding were entitled to be paid out our assets available for distribution to stockholders, before any payment is made to the holders of common stock, an amount per share equal to the greater of (a) the applicable original issue price for such series of redeemable convertible preferred stock, plus any dividends declared but unpaid thereon, or (b) such amount per share as would have been payable had all shares of redeemable convertible preferred stock been converted into common stock immediately prior to such liquidation, dissolution, winding up or deemed liquidation. After the payment of all preferential amounts required to be paid to the holders of redeemable convertible preferred stock, our remaining assets available for distribution to our stockholders shall be distributed among the holders of shares of common stock, pro rata based on the number of shares of common stock held by such holder.
If, upon any such liquidation, dissolution, winding up, or deemed liquidation event, our assets available for distribution to our stockholders were insufficient to pay the holders of shares of redeemable convertible preferred stock the full amount to which they were entitled, the holders of redeemable convertible preferred stock would share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect of the shares held by them upon such distribution if all amounts payable on the shares were paid in full.
Voting Rights
The holders of each share of redeemable convertible preferred stock had the right to one vote for each share of common stock into which such redeemable convertible preferred stock could then be converted and, with respect to such vote, holders of redeemable convertible preferred stock were entitled to vote together with the holders of common stock as a single class.
Conversion Rights
Each share of redeemable convertible preferred stock was convertible, at the option of the holder, into fully paid and non-assessable shares of common stock determined by dividing the applicable original issue price by the applicable conversion price in effect at the time of conversion. The original issue prices and initial conversion prices of Series A, Series B, Series C, Series D, and Series E redeemable convertible preferred stock were $1.0246, $2.2384, $3.3318, $4.4590, and $8.2968 per share, respectively. As of December 31, 2018, each share of Series A, Series B, Series C, Series D, and Series E redeemable convertible preferred stock was convertible into common stock on a one-for-one basis.
Shares of Series A, Series B, Series C, Series D, and Series E redeemable convertible preferred stock would be automatically converted into fully paid shares of common stock immediately upon the earlier of: (a) the closing of the sale of shares of common stock to the public at a minimum price of $8.9180 per share, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to common stock, in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $50.0 million of gross cash proceeds to us or (b) the date and time, or occurrence of an event, specified by vote or written consent of the holders of a majority of the outstanding shares of Series A, Series B, Series C, Series D and Series E redeemable convertible preferred stock, respectively.
Redemption Rights
On or after April 10, 2023, all outstanding shares of redeemable convertible preferred stock would be eligible to be redeemed for cash in full upon a written notice by a majority of the holders of the outstanding redeemable convertible preferred stock. In the event of redemption, each holder of redeemable convertible preferred stock was entitled to receive the original issue price per share, plus any declared but unpaid dividends, in three annual installments.
Undesignated Preferred Stock
In connection with our IPO in July 2019, we filed an Amended and Restated Certificate of Incorporation which authorizes the issuance of 100,000,000 shares of undesignated preferred stock, par value of $0.001 per share, with rights and preferences, including voting rights, designated from time to time by our board of directors. No shares of preferred stock were issued or outstanding as of December 31, 2019.
Common Stock
In December 2019, we completed a secondary offering in which certain stockholders sold 2,777,327 shares of common stock at an offering price of $27.00 per share. The selling stockholders received all of the net proceeds from the sale of shares in this offering. We did not sell any shares or receive any proceeds in this secondary offering.
In July 2019, upon completion of our IPO, we sold 14,590,050 shares of our common stock at an offering price of $28.00 per share, including 1,903,050 shares of common stock pursuant to the exercise in full of the underwriters' option to purchase additional shares. We raised net proceeds of $377.5 million, after deducting underwriting discounts and commissions of $28.6 million and offering costs of approximately $2.4 million. In connection with the IPO, we filed an Amended and Restated Certificate of Incorporation which authorizes the issuance of 900,000,000 shares of common stock with a par value of $0.001 per share.
In December 2018, certain of our employees and stockholders sold 2,138,302 shares of our common stock and 57,945 shares of our redeemable convertible preferred stock at a price of $7.4672 per share to investors. The purchase price per share in the secondary transaction was in excess of the fair value of our outstanding common stock at the time of the transaction and accordingly, upon the completion of the transaction, we recorded $2.3 million in stock-based compensation expense related to the excess of the sales price per share of common stock over the fair value of the our common stock at the time of the transaction. We did not sell any shares or receive any proceeds from the transaction.
In December 2017, certain of our employees and stockholders sold 605,345 shares of our common stock at a price of $1.88 per share to investors, which was the fair value of our common stock at the time of the transaction. We did not sell any shares or receive any proceeds from the transaction.
As of December 31, 2019 and 2018, we reserved shares of common stock, on an as-if-converted basis, for future issuance as follows:
 
December 31,
 
2019
 
2018
 
(in thousands)
Redeemable convertible preferred stock

 
58,615

Outstanding warrants to purchase common stock
695

 
785

Outstanding options to purchase common stock
14,020

 
17,571

Outstanding restricted stock units
5,208

 
1,827

Restricted stock awards subject to repurchase
736

 

Estimated shares for future ESPP purchase
890

 

Available for future issuance
8,160

 
1,741

Total
29,709

 
80,539


Common Stock Warrants
Common stock warrants outstanding as of December 31, 2019 are as follows:
Holder
 
Issue Date
 
Outstanding
Shares
 
Exercise
Price
 
Exercisable
Shares
 
Expiration
Date
 
 
(in thousands, except per share data)
Partner
 
3/1/2015
 
695

 
$
2.28

 
695

 
2/28/2025
 
 
 
 
695

 

 
695

 
 
Common stock warrants outstanding as of December 31, 2018 are as follows:
Holder
 
Issue Date
 
Outstanding
Shares
 
Exercise
Price
 
Exercisable
Shares
 
Expiration
Date
 
 
(in thousands, except per share data)
Bank
 
4/16/2015
 
28

 
$
0.36

 
28

 
9/5/2024
Bank
 
4/16/2015
 
63

 
$
0.80

 
63

 
4/16/2025
Partner
 
3/1/2015
 
694

 
$
2.28

 
694

 
2/28/2025
 
 
 
 
785

 
 
 
785

 
 

Warrant activities during the years ended December 31, 2019, 2018 and 2017 were:
 
Shares
 
(in thousands)
Balance as of January 1, 2017
2,188

Exercised
(361
)
Forfeited or expired
(1,042
)
Balance as of December 31, 2017
785

Exercised, forfeited or expired

December 31, 2018
785

Exercised
(90
)
December 31, 2019
695


Common stock warrants covering 90,277 shares of common stock were exercised during the year ended December 31, 2019 for proceeds of approximately $0.1 million. No warrants were exercised during the year ended December 31, 2018. During the year ended December 31, 2017, 361,425 common stock warrants were exercised for total proceeds of $0.3 million.